Objectives and strategies for rheumatoid arthritis therapy: Yesterday vs. today

Drugs of Today

Volumn 39, Issue SUPPL. B, 2003, Pages 3-8

  Smolen, Josef S ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; GOLD; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; SALICYLIC ACID;

CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; HUMAN; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SIDE EFFECT; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 0345307627     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. van der Heijde, D.M. Joint erosion and patients with early rheumatoid arthritis. Br J Rheumatol 1995, 34(Suppl. 2): 74-8.
2. Boers, M., Verhoeven, A.C., Markusse, H.M. et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997, 350: 309-18.
3. Peltomaa, R., Leirisalo-Repo, M., Heleve, T., Paimela, L. Effect of age on 3 year outcome in early rheumatoid arthritis. J Rheumatol 2000, 27: 638-43.
4. Aletaha, D., Eberl, G., Nell, V.P., Machold, K.P., Smolen, J.S. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years. Ann Rheum Dis 2002, 61: 630-4.
5. van der Heide, A., Jacobs, J.W., Bijlsma, J.W. et al. The effectiveness of early treatment with "second-line" antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 1996, 124: 699-707.
6. Lard, L.R., Visser, H., Speyuer, I. et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001, 111: 446-51.
7. Bathon, J.M., Martin, R.W., Fleischmann, R.M. et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000, 343: 1586-93.
8. Aletaha, D., Smolen, J.S. Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. J Rheumatol 2002, 29: 1631-8.
9. O'Dell, J.R., Leff, R., Paulsen, G. et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002, 46: 1164-70.
10. Proudman, S.M., Conaghan, P.G., Richardson, C. et al. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum 2000, 43: 1809-19.
11. Haagsma, C.J., van Riel, P.L., de Jong, A.J., van de Putte, L.B. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol 1997, 36: 1082-8.
12. Dougados, M., Combe, B., Cantagrel, A. et al. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis 1999, 58: 220-5.
13. Landewe, R.B., Boers, M., Verhoeven, C.A. et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002, 46(2): 347-56.
14. Prevoo, M.L., van't Hof, M.A., Kuper, H.H., van Leeuwen, M.A., van de Putte, L.B., van Riel, P.L. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38: 44-8.
15. Smolen, J.S., Breedveld, F.C., Emery, P. et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003, 42: 244-57.
16. Furst, D.E., Breedveld, F.C., Kalden, J.R. et al. Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002). Ann Rheum Dis 2002, 61 (Suppl. 2): ii2-ii7.
17. Smolen, J.S., Steiner, G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2003, 2: 473-88.